Özlem Türeci

TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings.

AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria.

IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Schenker AG provides logistics services. It offers solutions in the areas of land transport, air and ocean freight, contract logistics, and supply chain management. The company was founded by Gottfried Schenker in July 1872 and is headquartered in Essen, Germany.

Rhenus SE & Co. KG engages in the provision of logistics management services. It offers transport, warehouse, transshipment, and value added logistics services. The firm serves the chemical, trade, engineering, and automotive industry. The company was founded on November 13, 1912 and is headquartered in Holzwickede, Germany.

McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany.

Vanguard AG engages in the development, manufacture, and sale of medical devices and equipment used for cardiology and endoscopy. The company was founded by Bernard Frieling and Robert Schrödel in 1998 and is headquartered in Berlin, Germany.

APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany.

MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved.

apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany.

Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting.

Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023.

JPT Peptide Technologies GmbH provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery. The firm’s products include custom peptides, modified & labeled peptides, clinical peptides, stable isotope-labeled peptides, SPOT peptides, immunogenic peptides, peptide libraries, peptide pools, peptide microarrays, peptide ELISA, enzyme profiling and epitope discovery service. The company was founded in 2004 and is headquartered in Berlin, Germany.

AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany.

Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients.

CorTec GmbH develops a neuro-technological platform for brain activity measurement and stimulation. The firm specializes in the designing a platform based on the CorTec Brain Interchange technology, with focus on opening up therapeutic and diagnostic possibilities. Its application areas encompass treatment, rehabilitation, and assistance technique. The firm also engages in research and development partnerships that deal with technology development programs and funding initiatives. The company was founded by Thomas Stieglitz, Wolfgang Meier, Christina Schwartz, Jorn Rickert, Markus Raab, Christian Henle, Martin Schuttler, and Jorg Fischer in September 2010 and is headquartered in Freiburg, Germany.

Broermann Holding GmbH engages in the acquisition, management, and financing of firms, particularly hospitals and healthcare, hotels, and real estate sectors. The firm provides consulting services to such firms. The company was founded on June 19, 1985 and is headquartered in Koenigstein im Taunus, Germany.

Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier.

Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany.

ATB GmbH is an investment holding German company founded in 2004. The private company is based in Gera, Germany.

Part of Else Kröner-Fresenius-Stiftung, Hospitalia International GmbH is a German company that provides health care and other related services. The company is based in Bad Homburg, Germany. The CEOs of the company are Mirsad Midzic, Jens K. Schäkel, Rafael Garcia Feil.

LBG 2 GmbH provides residential real estate services. The private company is based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Thomas Maier.

Part of Jossa Arznei GmbH, Pharma Radebeul GmbH is a company that specializes in rentals and leases of industrial machinery. The company is based in Radebeul, Germany. Michael Riemenschneider has been the CEO of the German company since 2020.

Part of MediClin AG, MediClin Geschäftsführungs GmbH is a company based in Offenburg, Germany. The CEOs of the German company are Volker Hippler, Phillip Fröschle, Ute Haase, Philipp Schlösser, Tino Marco Fritz. MediClin Geschäftsführungs GmbH provides investment services.